Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelHartmut Döhner, Clara D. Bloomfield, Elihu H. Estey et al.|Blood|2016Cited by 5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNHartmut Döhner, Bob Löwenberg, Lucy A. Godley et al.|Blood|2022Cited by 3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> MutationRichard M. Stone, Hartmut Döhner, Sumithra J. Mandrekar et al.|New England Journal of Medicine|2017Cited by 2.2k
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemiaDonia M. Moujalled, Andrew H. Wei|Leukemia|2018Cited by 172
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemiasRachel Thijssen, Andrew H. Wei|Blood|2021Cited by 134